HKMPF News and Press, Hikma Pharmaceuticals Plc From 02/22/24

2024-02-22 12:33:03 ET Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Conference Call February 22, 2024, 07:00 AM ET Company Participants Susan Ringdal - EVP, Strategic Planning and Global Affairs Riad Mishlawi - CEO Khalid Nabilsi - CFO Bill Larkins - He...

2024-01-09 03:48:00 ET Summary In terms of dividend yield, there was a clear gap between the portfolio’s yield and the All-Share's yield throughout 2023 and by the end of the year, the portfolio had a dividend yield of exactly 5% compared to the FTSE All-Share’s yield of...

2023-12-01 13:40:47 ET More on Amarin, Amneal, etc. Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript ...

2023-08-08 13:35:40 ET Hikma Pharmaceuticals ( OTCPK:HKMPF ) had declared $0.25/share quarterly dividend Payable Sept. 15; for shareholders of record Aug. 11; ex-div Aug. 9. See HKMPF Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...

2023-08-04 12:18:02 ET Hikma Pharmaceuticals PLC (HKMPF) Q2 2023 Earnings Conference Call August 03, 2023 04:30 AM ET Company Participants Susan Ringdal - Executive Vice President, Strategic Planning & Global Affairs Said Darwazah - Chief Executive Officer Ri...

2023-08-04 06:50:57 ET Hikma Pharmaceuticals press release ( OTCPK:HKMPF ): 1H GAAP EPS of $59.30. Revenue of $1.43B (+18.2% Y/Y). For further details see: Hikma Pharmaceuticals GAAP EPS of $59.30, revenue of $1.43B

2023-05-23 06:21:26 ET Shanghai Junshi Biosciences ( OTCPK:SHJBF ) said China's National Medical Products Administration (NMPA) accepted an application seeking expanded approval of toripalimab, in combination with albumin-bound paclitaxel, to treat PD-L1 positive (CPS ≥ 1) untrea...

2023-05-06 05:25:00 ET Summary Hikma Pharmaceuticals is a FTSE 250 generic drug manufacturer that was founded in the Middle East in 1978. The company has many attractive features, including a long track record of progressive dividend growth, so I added it to my dividend portfolio ...

2023-03-29 06:05:32 ET Shanghai Junshi Biosciences ( OTCPK:SHJBF ) is collaborating with Rxilient Biotech to develop and sell cancer drug toripalimab through a joint venture, Excellmab, in nine Southeast Asian nations. Under the agreement, Rxilient will subscribe ...

The following slide deck was published by Hikma Pharmaceuticals PLC in conjunction with their 2022 Q4 earnings call. For further details see: Hikma Pharmaceuticals PLC 2022 Q4 - Results - Earnings Call Presentation